INNOVATALK #2: Cancer measurement at the point of care

20 Jul 2022
INNOVATALK #2: Cancer measurement at the point of care

Among the VinFuture Prize’s most important missions are disseminating scientific and technological knowledge to the public, and connecting generations of young scientists, inventors, and entrepreneurs with globally established inventors for potential partnerships. To realize these missions, we have organized a series of sci-tech sharing webinars based on meaningful innovations.

In the July’s webinar on personalized medicine, we are pleased to invite you to meet Professor Brian T. Cunningham from the University of Illinois Urbana-Champaign with his innovation on Cancer Measurement at the Point of Care.

Invited by the VinFuture Prize, untold stories of cancer measurement at the point of care will be told by top global scientists in the field of personalized medicine.

Please find below the details of the webinar:

  • Date & time: July 26, 2022, 9:00 am Vietnam time (ICT), which corresponds to July 25, 2022 at 7:00 pm in Los Angeles, 9:00 pm in Bogota and 10:00 pm in New York
  • Chair: Professor Chi Van Dang – Member of the VinFuture Prize Council, Scientific Director of the Ludwig Institute for Cancer Research, overseeing Ludwig branches around the globe. He is the Editor-in-Chief of Cancer Research, a foundational and influential AACR journal. Professor Dang was the Director of the Division of Hematology at Johns Hopkins Hospital, Vice Dean for Research at Hopkins Medicine and served as the Director of the Abramson Cancer Center at the University of Pennsylvania. He was a member of the US Cancer Moonshot Blue Ribbon Panel. He will return to Johns Hopkins in October 2022 as Bloomberg Distinguished Professor in oncology and biochemistry & molecular biology. He is a member of the National Academy of Medicine, a fellow of the American Academy of Arts & Science and the American Association for Cancer Research Academy. His laboratory established the first mechanistic link between a cancer gene, MYC, and cellular energy metabolism, providing the conceptual foundation to exploit the metabolic vulnerabilities of cancers for therapy. His current work extends the role of MYC and the circadian clock in metabolism, immunity and cancer.
  • Speaker: Professor Brian Cunningham – Intel Alumni Endowed Chair of the Department of Electrical and Computer Engineering, Director of Center for Pathogen Diagnostics, Professor at Illinois Cancer Center, Woese Institute for Genomic Biology, Holonyak Micro and Nanotechnology Laboratory, University of Illinois Urbana-Champaign. He is a fellow of the Royal Society of Chemistry in 2020, a former Distinguished Lecturer of the Institute of Electrical and Electronics Engineers – the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity and former Chairperson of NIH Study Section on Instrument and System Development. Dr. Cunningham was a co-founder of SRU Biosystems in 2000 and founded Exalt Diagnostics in 2012 to commercialize photonic crystal enhanced fluorescence technology for disease biomarker detection. His research group is focused on the application of sub-wavelength optical phenomena and fabrication methods to the development of novel devices and instrumentation for the life sciences.
  • Location: via Zoom (the webinar link will be provided after your attendance confirmation at the registration link)
  • Audience: scientists, inventors, and entrepreneurs in science and technology across the world
  • The language used in the webinar is English, and Vietnamese translation will be provided.

Each webinar will be followed by a Q&A session, during which you are very much encouraged to make questions directly to the Keynote Speaker and the Chair, to open potential partnerships between you and these leading innovators.

Please rewatch this webinar via:


    By ticking this box, you have given us consent to send you regular newsletters and process your data as per this privacy policy. You may otp out anytime in the future.